MedTrace Logo

Inspiratory Muscle Training for Chronic Kidney Disease Patients on Hemodialysis

NCT05241652 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-03-22

No results posted yet for this study

Summary

Chronic Kidney Disease (CKD) is a global public health problem with an increasing prevalence and incidence, poor prognosis, and high costs. It is characterized by changes in the kidney structure and functions for more than three months. It is grouped into several stages, including end-stage kidney disease requiring renal replacement therapy (RRT). Hemodialysis (HD) is one of the RRT options other than kidney transplantation. Regular moderate-intensity exercise may improve certain elements of the immune system and have anti-inflammatory benefits. Aerobic exercise, extremity muscle strength exercises, and inspiratory muscle training have been reported to improve kidney function and quality of life in CKD patients receiving hemodialysis three times a week. However, the effect of inspiratory muscle training on kidney and immune function, and quality of life in CKD patients receiving HD twice a week remains unclear.

Conditions

  • Chronic Kidney Disease Stage 5 on Dialysis

Interventions

OTHER

Inspiratory Muscle Training with an intensity of 50% MIP

Patients received IMT exercise program at a 50% MIP intensity for 12 weeks

OTHER

Inspiratory Muscle Training with an intensity of 10% MIP

Patients received IMT exercise program at a 10% MIP intensity for 12 weeks

Sponsors & Collaborators

  • Universitas Padjadjaran

    lead OTHER

Principal Investigators

  • Irma Ruslina Defi, M.D., Ph.D. · Universitas Padjadjaran

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
54 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-20
Primary Completion
2022-04-26
Completion
2022-05-05

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05241652 on ClinicalTrials.gov